Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Fertility

 

NMC growth makes it a FTSE 100 one to watch

London-listed Middle Eastern healthcare group NMC Health saw impressive 31% revenue growth – half organic - and 43% EBITDA growth in 2017. Net profit, margin and EPS are also up, and the healthcare segment has outperformed distribution significantly.

Qualitas’ IPO plan on Singapore Exchange faces challenges

Malaysia-based outpatient and corporate care group Qualitas’ planned IPO on the Singapore Exchange is “work in progress” and has been delayed to later this year, a well-placed source tells Healthcare Nova. HCN reported at the end of 2017 that Qualitas was planning to list on Singapore Exchange (SGX) to raise S$200m (US$152m) in early 2018. […]

Medical tourists “will return to Egypt”

Dr Ismail Aboul Foutouh, the CEO and founder of IVF centre Bedaya Hospital, gives Healthcare Nova an overview of the biggest IVF provider sector the Middle East and says why he believes there will be a revival of medical tourism in the country.

IVF/lab group sells stake to Oaktree; buys in Italy, Spain and Switzerland

NL Holding has sold a 30% stake to Oaktree Capital, while simultaneously acquiring fertility providers and specialised diagnostic laboratories in Switzerland, Italy and Spain. This coincides with Oaktree offloading its pan-European dentistry platform. We take a more detailed look at what NL has bought. 

Are you ready for GDPR?

The clock is ticking for businesses to comply with the General Data Protection Regulation, which comes into force on May 25. Healthcare Europa talks to Aetna International's CIO Alan Payne to find out what the data handling regulations mean for healthcare insurers and operators, and the challenges on the path to compliance.

Interview: Richard Banks, Virtus Health

Australia-based fertility network Virtus Health Limited runs a series of clinics in Ireland, is making inroads in Denmark, and has a presence in Singapore. Healthcare Europa talks to European MD Richard Banks about strategy, expansion, and the market.

NMC Health targets European fertility in 2018

London-listed healthcare provider NMC Health plans to grow its fertility business in Europe through M&A activity. It has $US800m to grow its business globally in the coming years. We talk to the group's CFO. 

Fertility giant bought by billionaire Russian

Russia's largest fertility operator AVA-Peter Clinic has been acquired by one of the country's richest men. We talk to a well-placed contact about what this might mean for a market that has seen a dearth of M&A activity in recent years.

Find Us